In this study, we evaluated the anti-tumor activity of scoparone against DU145 androgen-independent prostate-cancer cells and found that its molecular mechanisms of action are associated with inhibition of STAT3 activity. This evidence concerns the gene STAT3 and Familial prostate cancer.